TOKYO -- Japan's trade deficit in medical goods is likely to top 3 trillion yen ($26.45 billion) in 2021 for the first time as the nation loses its market presence in the era of biopharmaceutical drugs.
The delayed authorization and slow development of coronavirus vaccines in Japan have exposed deeper problems. (Source photo by Takaki Kashiwabara)
Datawatch
Japan falling behind in developing biopharmaceutical drugs
Trade deficit in medicines likely to top $26bn in 2021 due to weak R&D
Read Next
Latest on Datawatch
